To investigate the potential use of vitamin C in treating hematological malignancies, Cimmino and colleagues treated mouse HSPCs and human leukemia cells with vitamin C. They found that vitamin C treatment mimics TET2 restoration in Tet2-deficient mouse HSPCs by increasing 5hmC formation, as seen in other studies [88]. The gene discussed is TET2; the disease is leukemia.